Correction: Determining cost and placement decisions for moderate complexity NAATs for tuberculosis drug susceptibility testing. by Akash Malhotra, Ryan Thompson, Margaretha De Vos, Anura David, Samuel Schumacher, Hojoon Sohn

Get full text

Determining cost and placement decisions for moderate complexity NAATs for tuberculosis drug susceptibility testing. by Akash Malhotra, Ryan Thompson, Margaretha De Vos, Anura David, Samuel Schumacher, Hojoon Sohn

Get full text

Cost and cost-effectiveness of pediatric home-based versus facility-based TB Preventive Treatment in Ethiopia (CHIP-TB). by Akash Malhotra, Ahmed Bedru, Fiseha Mulatu, Bareng A S Nonyane, Silvia Cohn, Christiaan Mulder, Samuel Bayu, Stephanie Borsboom, Gidea Conradie, Jonathan E Golub, Richard E Chaisson, Gavin Churchyard, David W Dowdy, Hojoon Sohn, Nicole Salazar-Austin

Get full text

Cost and cost-effectiveness of pediatric home-based versus facility-based TB Preventive Treatment in Ethiopia (CHIP-TB) by Akash Malhotra, Ahmed Bedru, Fiseha Mulatu, Bareng A.S. Nonyane, Silvia Cohn, Christiaan Mulder, Samuel Bayu, Stephanie Borsboom, Gidea Conradie, Jonathan E. Golub, Richard E. Chaisson, Gavin Churchyard, David W. Dowdy, Hojoon Sohn, Nicole Salazar-Austin

Get full text

Decentralized TB diagnostic testing with Truenat MTB Plus and MTB-RIF Dx vs. hub-and-spoke GeneXpert MTB/RIF Ultra in Mozambique and Tanzania: a cost and cost-effectiveness analysi... by Akash Malhotra, Délio Elísio, Antonio Machiana, Anange Lwilla, Jerry Hella, Neenah Young, Celso Khosa, Marta Cossa, Dinis Nguenha, Regino Mgaya, Dionisia Balate, Mikaela Watson, Vinzeigh Leukes, Lelisa Fekadu, Saima Bashir, Adam Penn-Nicholson, Morten Ruhwald, Leyla Larsson, Monisha Sharma, Katharina Kranzer, Claudia M. Denkinger, David Dowdy

Get full text